Download Citation
Article Source:
Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients
Gandhi AK,
Shi T,
Li M,
Jungnelius U,
Romano A,
et al.
(2013)
Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients.
PLOS ONE 8(11): e80437.
https://doi.org/10.1371/journal.pone.0080437